Evolus, Inc.
EOLS
$6.70
$0.020.30%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 301.79M | 297.18M | 285.82M | 277.94M | 275.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 301.79M | 297.18M | 285.82M | 277.94M | 275.46M |
| Cost of Revenue | 102.44M | 100.07M | 95.37M | 91.23M | 87.01M |
| Gross Profit | 199.35M | 197.11M | 190.45M | 186.71M | 188.46M |
| SG&A Expenses | 216.13M | 220.79M | 216.38M | 216.07M | 209.54M |
| Depreciation & Amortization | 5.06M | 4.35M | 3.61M | 2.79M | 2.52M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 333.23M | 334.78M | 323.88M | 318.88M | 308.38M |
| Operating Income | -31.44M | -37.60M | -38.06M | -40.94M | -32.91M |
| Income Before Tax | -42.56M | -50.96M | -57.83M | -61.30M | -55.51M |
| Income Tax Expenses | 861.00K | 677.00K | 732.00K | 699.00K | 689.00K |
| Earnings from Continuing Operations | -43.42 | -51.64 | -58.56 | -62.00 | -56.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.42M | -51.64M | -58.56M | -62.00M | -56.20M |
| EBIT | -31.44M | -37.60M | -38.06M | -40.94M | -32.91M |
| EBITDA | -23.15M | -30.09M | -31.43M | -35.18M | -27.46M |
| EPS Basic | -0.67 | -0.80 | -0.91 | -0.97 | -0.89 |
| Normalized Basic EPS | -0.48 | -0.54 | -0.55 | -0.58 | -0.47 |
| EPS Diluted | -0.67 | -0.80 | -0.91 | -0.97 | -0.89 |
| Normalized Diluted EPS | -0.48 | -0.54 | -0.55 | -0.58 | -0.47 |
| Average Basic Shares Outstanding | 259.35M | 257.86M | 256.33M | 254.75M | 252.94M |
| Average Diluted Shares Outstanding | 259.80M | 258.31M | 256.33M | 254.75M | 252.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |